Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-10-08

Clinical Trial Update: PREVENTION OF WORSENING RENAL FUNCTION OF INTRAVENUS ALBUMIN IN HEART FAILURE PATIENTS [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update indicating recruitment for intravenous albumin to prevent worsening renal function in heart failure patients with diuretic thera…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • intravenous albumin (albumin)

Snippet

Sponsor: Democritus University of Thrace | Conditions: Diuretics Drug Reactions, Heart Failure; With Decompensation | Phase 3 | Status: RECRUITING